|
GS210158: GO:0006084 acetyl-CoA metabolic process
|
|
GS136290: morphine antinociception 2 (Morph2, Published QTL Chr 9)
|
|
GS135298: alcohol preference QTL 1 (Alpq1, Published QTL Chr 9)
|
|
GS136869: triglyceride QTL 1 (Trigq1, Published QTL Chr 9)
|
|
GS135716: dermititis 1 (Derm1, Published QTL Chr 9)
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS168446: MP:0000631 abnormal neuroendocrine gland morphology
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS172294: HP:0001510 Growth delay
|
|
GS136709: susceptibility to lung cancer 10 (Sluc10, Published QTL Chr 9)
|
|
GS208404: GO:0045333 cellular respiration
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS178388: GO:0055114 oxidation-reduction process
|
|
GS135548: CD4 T cell subset 4 (Cd4ts4, Published QTL Chr 9)
|
|
GS135619: cholesterol 11 (Chol11, Published QTL Chr 9)
|
|
GS136812: type 2 diabetes modifying QTL 1 (Tdmq1, Published QTL Chr 9)
|
|
GS124417: Propylthiouracil interacting genes (MeSH:D011441) in CTD
|
|
GS136117: body length 4 (Lgth4, Published QTL Chr 9)
|
|
GS135354: BALB/c autoimmunity 1 (Baa1, Published QTL Chr 9)
|
|
GS136266: modifier of mammary tumor progression 3 (Mmtp3, Published QTL Chr 9)
|
|
GS174664: HP:0006737 Extraadrenal pheochromocytoma
|
|
GS176151: HP:0000256 Macrocephaly
|
|
GS179795: GO:0019866 organelle inner membrane
|
|
GS175538: HP:0011276 Vascular skin abnormality
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS201556: GO:0000104 succinate dehydrogenase activity
|
|
GS170969: HP:0000157 Abnormality of the tongue
|
|
GS210660: GO:0006121 mitochondrial electron transport, succinate to ubiquinone
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS165839: MP:0009701 abnormal birth body size
|
|
GS170836: HP:0011772 Abnormality of thyroid morphology
|
|
GS174906: HP:0000545 Myopia
|
|
GS207864: GO:0009055 electron carrier activity
|
|
GS174607: HP:0001605 Vocal cord paralysis
|
|
GS166643: MP:0010055 abnormal sensory neuron physiology
|
|
GS171718: HP:0002808 Kyphosis
|
|
GS186213: GO:0022904 respiratory electron transport chain
|
|
GS166225: MP:0009850 embryonic lethality between implantation and placentation
|
|
GS84213: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS172058: HP:0002331 Headache (with pheochromocytoma)
|
|
GS199767: GO:0006099 tricarboxylic acid cycle
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS128598: Ethanol Induced Ataxia Chr#9
|
|
GS172137: HP:0002858 Meningioma
|
|
GS135351: Alzheimer's disease modifier 3 (Azdm3, Published QTL Chr 9)
|
|
GS182519: GO:0006732 coenzyme metabolic process
|
|
GS183543: GO:0051179 localization
|
|
GS193215: GO:0006084 acetyl-CoA metabolic process
|
|
GS135647: cocaine induced activation 10 (Cocia10, Published QTL Chr 9)
|
|
GS136500: proteoglycan induced arthritis 5 (Pgia5, Published QTL Chr 9)
|
|
GS135527: castaneus 10 week body weight 2 (C10bw2, Published QTL Chr 9)
|
|
GS136938: vertebral trabecular bone trait 6 (Vtbt6, Published QTL Chr 9)
|
|
GS171436: HP:0000077 Abnormality of the kidney
|
|
GS174098: HP:0011792 Neoplasm by histology
|
|
GS136556: protection against vaginal candidiasis 2 (Pvcan2, Published QTL Chr 9)
|
|
GS176049: HP:0002377 Paraganglioma-related cranial nerve palsy
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS176765: HP:0001009 Telangiectasia
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS172342: HP:0010615 Angiofibromas
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS197469: GO:0044455 mitochondrial membrane part
|
|
GS171226: HP:0000812 Abnormal internal genitalia
|
|
GS136507: prion incubation determinant 2 (Pid2, Published QTL Chr 9)
|
|
GS135536: caffeine metabolism QTL 3 (Cafq3, Published QTL Chr 9)
|
|
GS176913: HP:0002170 Intracranial hemorrhage
|
|
GS181430: GO:0006637 acyl-CoA metabolic process
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS198220: GO:0006637 acyl-CoA metabolic process
|
|
GS175390: HP:0011007 Age of onset
|
|
GS182173: GO:0031967 organelle envelope
|
|
GS186744: GO:0043226 organelle
|
|
GS164991: MP:0003674 oxidative stress
|
|
GS182835: GO:0005622 intracellular
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS173145: HP:0011281 Abnormality of urine catecholamine concentration
|
|
GS176988: HP:0008046 Abnormality of the retinal vasculature
|
|
GS83993: cocaine related behavior 9 (Cocrb9, Published QTL, Chr 9)
|
|
GS176561: HP:0001011 Diaphoresis (with pheochromocytoma)
|
|
GS193942: GO:0035383 thioester metabolic process
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS84217: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS184448: GO:0044425 membrane part
|
|
GS176392: HP:0000740 Anxiety (with pheochromocytoma)
|
|
GS206742: GO:0043167 ion binding
|
|
GS175500: HP:0000517 Abnormality of the lens
|
|
GS177695: GO:0051187 cofactor catabolic process
|
|
GS166590: MP:0002873 normal phenotype
|
|
GS180298: GO:0005506 iron ion binding
|
|
GS174848: HP:0200008 Intestinal polyposis
|
|
GS174605: HP:0001609 Hoarse voice
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS136644: serum IGFBP-5 level QTL 3 (Si5lq3, Published QTL Chr 9)
|
|
GS170791: HP:0010978 Abnormality of immune system physiology
|
|
GS181473: GO:0005488 binding
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS179709: GO:0042775 mitochondrial ATP synthesis coupled electron transport
|
|
GS207616: GO:0016020 membrane
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS173119: HP:0002315 Headache
|
|
GS35611: Cerebellum Gene expression correlates of Morphine photocell counts minutes 15-30 in Females BXD
|
|
GS171035: HP:0002620 Systemic artery abnormality
|
|
GS198971: GO:0031966 mitochondrial membrane
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS198755: GO:0016491 oxidoreductase activity
|
|
GS176989: HP:0008047 Abnormality of the vasculature of the eye
|
|
GS35276: Striatum Gene expression correlates of Maximum startle response to 85 db in Males BXD
|
|
GS174610: HP:0001606 Vocal cord paralysis (caused by tumor impingement)
|
|
GS136166: leishmaniasis resistance 2 (Lmr2, Published QTL Chr 9)
|
|
GS198058: GO:0005743 mitochondrial inner membrane
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS175529: HP:0000001 All
|
|
GS169902: MP:0008504 abnormal adrenal chromaffin cell morphology
|
|
GS171920: HP:0002668 Paraganglioma
|
|
GS194138: GO:0005739 mitochondrion
|
|
GS175064: HP:0000975 Hyperhidrosis
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS175081: HP:0006753 Neoplasm of the stomach
|
|
GS174437: HP:0005114 Abnormalities of the peripheral arteries
|
|
GS174723: HP:0000771 Gynecomastia
|
|
GS173810: HP:0002597 Abnormality of the vasculature
|
|
GS176021: HP:0010927 Abnormality of divalent inorganic cation homeostasis
|
|
GS172026: HP:0000361 Pulsatile tinnitus (tympanic paraganglioma)
|
|
GS173872: HP:0011368 Epidermal thickening
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS135675: cholesterol QTL 4 (Cq4, Published QTL Chr 9)
|
|
GS204477: GO:0045281 succinate dehydrogenase complex
|
|
GS197087: GO:0016310 phosphorylation
|
|
GS175556: HP:0011675 Arrhythmia
|
|
GS208012: GO:0044464 cell part
|
|
GS201252: GO:0044425 membrane part
|
|
GS136453: postnatal body weight growth 15 (Pbwg15, Published QTL Chr 9)
|
|
GS136643: serum IGFBP-5 level QTL 2 (Si5lq2, Published QTL Chr 9)
|
|
GS135267: alopecia areata 2 (Alaa2, Published QTL Chr 9)
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS175164: HP:0011927 Short digit
|
|
GS170980: HP:0011362 Abnormal hair quantity
|
|
GS201250: GO:0044429 mitochondrial part
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS176771: HP:0001000 Abnormality of skin pigmentation
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS171599: HP:0001962 Palpitations
|
|
GS171791: HP:0000370 Abnormality of the middle ear
|
|
GS168809: MP:0003243 abnormal dopaminergic neuron morphology
|
|
GS1778: Tabakoff et al 2003: Differential Gene Expression of acute functional tolerance to an incoordinating effect of ethanol (HAFT2 vs LAFT2)
|
|
GS176092: HP:0100006 Neoplasm of the central nervous system
|
|
GS167560: MP:0001001 abnormal chemoreceptor morphology
|
|
GS169833: MP:0005380 embryogenesis phenotype
|
|
GS182966: GO:0006099 tricarboxylic acid cycle
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS209846: GO:0046356 acetyl-CoA catabolic process
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS121976: Zidovudine interacting genes (MeSH:D015215) in CTD
|
|
GS208795: GO:0015980 energy derivation by oxidation of organic compounds
|
|
GS168810: MP:0003244 loss of dopaminergic neurons
|
|
GS176091: HP:0100007 Neoplasm of the peripheral nervous system
|
|
GS173952: HP:0000853 Goiter
|
|
GS136756: susceptibility to Salmonella typhimurium antigens 7 (Ssta7, Published QTL Chr 9)
|
|
GS171968: HP:0000405 Conductive hearing impairment
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS170368: MP:0000249 abnormal blood vessel physiology
|
|
GS196468: GO:0042775 mitochondrial ATP synthesis coupled electron transport
|
|
GS199634: GO:0005623 cell
|
|
GS171900: HP:0011452 Functional abnormality of the middle ear
|
|
GS171415: HP:0000138 Ovarian cysts
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS174950: HP:0200043 Verrucae
|
|
GS174198: HP:0009720 Adenoma sebaceum
|
|
GS135322: APP associated premature death 1 (Appd1, Published QTL Chr 9)
|
|
GS164909: MP:0008289 abnormal adrenal medulla morphology
|
|
GS198970: GO:0031967 organelle envelope
|
|
GS136547: periosteal circumference 6 (Pstc6, Published QTL Chr 9)
|
|
GS172500: HP:0007400 Irregular hyperpigmentation
|
|
GS201256: GO:0044422 organelle part
|
|
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
|
|
GS135821: ethanol consumption 3 (Etohc3, Published QTL Chr 9)
|
|
GS136841: T lymphocyte fraction 2 (Tlf2, Published QTL Chr 9)
|
|
GS173929: HP:0001676 Palpitations (with pheochromocytoma)
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS35606: Cerebellum Gene expression correlates of Morphine photocell counts minutes 15-30 in Females & Males BXD
|
|
GS175928: HP:0000240 Abnormality of skull size
|
|
GS176540: HP:0002721 Immunodeficiency
|
|
GS176973: HP:0001072 Thickened skin
|
|
GS135300: alcohol preference QTL 3 (Alpq3, Published QTL Chr 9)
|
|
GS84216: alcohol consumption (Published QTL, Chr 9)
|
|
GS176569: HP:0008069 Neoplasm of the skin
|
|
GS128581: BECs at LORR Recovery Chr# 9
|
|
GS173419: HP:0000147 Polycystic ovaries
|
|
GS176735: HP:0010929 Abnormality of cation homeostasis
|
|
GS84215: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS84209: morphine antinociception (Published QTL, Chr 9)
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS136163: leishmaniasis resistance 17 (Lmr17, Published QTL Chr 9)
|
|
GS202498: GO:0009109 coenzyme catabolic process
|
|
GS171157: HP:0100742 Vascular neoplasm
|
|
GS172283: HP:0000820 Abnormality of the thyroid gland
|
|
GS135239: activity response to ethanol 6 (Actre6, Published QTL Chr 9)
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS182683: GO:0020037 heme binding
|
|
GS174001: HP:0010614 Fibroma
|
|
GS199267: GO:0043234 protein complex
|
|
GS136939: vertebral trabecular bone trait 7 (Vtbt7, Published QTL Chr 9)
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS135371: B.burgdorferi-associated arthritis 9 (Bbaa9, Published QTL Chr 9)
|
|
GS176196: HP:0004796 Gastrointestinal obstruction
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS165811: MP:0009703 decreased birth body size
|
|
GS166331: MP:0005156 bradykinesia
|
|
GS174247: HP:0000539 Abnormality of refraction
|
|
GS171279: HP:0100545 Arterial stenosis
|
|
GS185666: GO:0009109 coenzyme catabolic process
|
|
GS170983: HP:0100634 Neuroendocrine neoplasm
|
|
GS166559: MP:0001905 abnormal dopamine level
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS173569: HP:0003574 Positive regitine blocking test
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS176774: HP:0001005 Dermatological manifestations of systemic disorders
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS174606: HP:0001608 Abnormality of the voice
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS175616: HP:0008629 Pulsatile tinnitus
|
|
GS165260: MP:0001392 abnormal locomotor behavior
|
|
GS169603: MP:0001672 abnormal embryogenesis/ development
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS121771: Benzbromarone interacting genes (MeSH:D001553) in CTD
|
|
GS172544: HP:0000834 Abnormality of the adrenal glands
|
|
GS173761: HP:0000519 Congenital cataract
|
|
GS125936: Tunicamycin interacting genes (MeSH:D014415) in CTD
|
|
GS209291: GO:0046914 transition metal ion binding
|
|
GS171923: HP:0100579 Mucosal telangiectasiae
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS165385: MP:0008946 abnormal neuron number
|
|
GS171621: HP:0100851 Abnormal emotion/affect behavior
|
|
GS171345: HP:0001048 Cavernous hemangioma
|
|
GS171067: HP:0002664 Neoplasm
|
|
GS181790: GO:0006119 oxidative phosphorylation
|
|
GS121369: Clofibric Acid interacting genes (MeSH:D002995) in CTD
|
|
GS174102: HP:0011799 Abnormality of facial soft tissue
|
|
GS164032: MP:0004811 abnormal neuron physiology
|
|
GS170601: MP:0005621 abnormal cell physiology
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS187277: GO:0009060 aerobic respiration
|
|
GS192354: GO:0046914 transition metal ion binding
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS172429: HP:0002640 Hypertension associated with pheochromocytoma
|
|
GS136038: inflammatory bowel disease QTL 1 (Ibdq1, Published QTL Chr 9)
|
|
GS135618: cholesterol 10 (Chol10, Published QTL Chr 9)
|
|
GS166718: MP:0002169 no abnormal phenotype detected
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS175602: HP:0002087 Abnormality of the upper respiratory tract
|
|
GS166160: MP:0011092 complete embryonic lethality
|
|
GS175999: HP:0100659 Abnormality of the cerebral vasculature
|
|
GS175512: HP:0005214 Intestinal obstruction
|
|
GS202364: GO:0048037 cofactor binding
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS203594: GO:0043226 organelle
|
|
GS173894: HP:0003334 Elevated circulating catecholamine level
|
|
GS84214: differences in cocaine responsiveness (Published QTL, CHr 9)
|
|
GS171680: HP:0100642 Neoplasm of the adrenal medulla
|
|
GS184750: GO:0000104 succinate dehydrogenase activity
|
|
GS172391: HP:0000221 Furrowed tongue
|
|
GS177696: GO:0051186 cofactor metabolic process
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS198078: GO:0005749 mitochondrial respiratory chain complex II
|
|
GS175530: HP:0000002 Abnormality of body height
|
|
GS135343: atherosclerosis 29 (Ath29, Published QTL Chr 9)
|
|
GS136407: organ weight QTL 7 (Orgwq7, Published QTL Chr 9)
|
|
GS166502: MP:0003186 abnormal redox activity
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS135911: G protein deficiency-induced colitis 3 (Gpdc3, Published QTL Chr 9)
|
|
GS84211: cocaine related behavior (Published QTL, Chr 9)
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS171701: HP:0100568 Neoplasm of the endocrine system
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS171115: HP:0001053 Hypopigmented skin patches
|
|
GS35261: Striatum Gene expression correlates of Maximum startle response to 80 db in Females BXD
|
|
GS172763: HP:0001686 Loss of voice
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS83965: cocaine induced activation 10 (Cocia10, Published QTL, Chr 9, MGI:3040201)
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS168750: MP:0002191 abnormal artery morphology
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS172679: HP:0001028 Hemangioma
|
|
GS163227: MP:0003313 abnormal locomotor activation
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS174861: HP:0006723 Intestinal carcinoid
|
|
GS136801: "body temperature response to dietary restriction, QTL 1" (Tbdr1, Published QTL Chr 9)
|
|
GS171443: HP:0008777 Abnormality of the vocal cords
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
|
|
GS175068: HP:0000971 Abnormality of the sweat gland
|
|
GS181270: GO:0005743 mitochondrial inner membrane
|
|
GS165985: MP:0000965 abnormal sensory neuron morphology
|
|
GS180166: GO:0008152 metabolic process
|
|
GS192900: GO:0046356 acetyl-CoA catabolic process
|
|
GS167105: MP:0008948 decreased neuron number
|
|
GS177048: HP:0011371 Recurrent viral skin infections
|
|
GS171687: HP:0003072 Hypercalcemia
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS36193: Cerebellum Gene expression correlates of Locomotor activity after second saline treatment. in Males BXD
|
|
GS136084: keratinocyte stem cell locus 1 (Ksc1, Published QTL Chr 9)
|
|
GS164970: MP:0000639 abnormal adrenal gland morphology
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS167245: MP:0003437 abnormal carotid body morphology
|
|
GS171100: HP:0000759 Abnormality of the peripheral nervous system
|
|
GS174401: HP:0001613 Hoarse voice (caused by tumor impingement)
|
|
GS175074: HP:0001156 Brachydactyly syndrome
|
|
GS177317: GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
|
|
GS192509: GO:0006810 transport
|
|
GS175537: HP:0011277 Abnormality of the urinary system physiology
|
|
GS172281: HP:0000822 Hypertension
|
|
GS135579: cystic fibrosis modifier QTL 2 (Cfmq2, Published QTL Chr 9)
|
|
GS172040: HP:0000962 Hyperkeratosis
|
|
GS136764: soft tissue heal 8 (Stheal8, Published QTL Chr 9)
|
|
GS174877: HP:0001892 Abnormal bleeding
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS176560: HP:0001010 Hypopigmentation of the skin
|
|
GS136024: hypothermia sensitivity (Hts, Published QTL Chr 9)
|
|
GS168956: MP:0003491 abnormal voluntary movement
|
|
GS172376: HP:0002864 Paraganglioma of head and neck
|
|
GS190714: GO:0016020 membrane
|
|
GS176477: HP:0002118 Abnormality of the cerebral ventricles
|
|
GS174837: HP:0001095 Hypertensive retinopathy
|
|
GS172446: HP:0003001 Glomus jugular tumor
|
|
GS174289: HP:0002577 Abnormality of the stomach
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS169957: MP:0001402 hypoactivity
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS135595: mean cell hemoglobin concentration QTL 2 (Chcmq2, Published QTL Chr 9)
|
|
GS175128: HP:0011123 Inflammatory abnormality of the skin
|
|
GS175738: HP:0011732 Abnormality of adrenal morphology
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS175283: HP:0006748 Adrenal pheochromocytoma
|
|
GS196470: GO:0042773 ATP synthesis coupled electron transport
|
|
GS170673: MP:0010913 abnormal neuroendocrine cell morphology
|
|
GS174608: HP:0001604 Vocal cord paresis
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS177000: HP:0001291 Abnormality of the cranial nerves
|
|
GS136379: obesity QTL 5 (Obq5, Published QTL Chr 9)
|
|
GS174099: HP:0011793 Neoplasm by anatomical site
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS198263: GO:0005488 binding
|
|
GS203053: GO:0022900 electron transport chain
|
|
GS202368: GO:0048038 quinone binding
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS35271: Striatum Gene expression correlates of Maximum startle response to 85 db in Females BXD
|
|
GS172352: HP:0000137 Abnormality of the ovary
|
|
GS171351: HP:0003581 Adult onset
|
|
GS175431: HP:0011122 Abnormality of skin physiology
|
|
GS125402: Diethylnitrosamine interacting genes (MeSH:D004052) in CTD
|
|
GS166015: MP:0006036 abnormal mitochondrial physiology
|
|
GS163896: MP:0011479 abnormal catecholamine level
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS204180: GO:0070469 respiratory chain
|
|
GS175840: HP:0000739 Anxiety
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS172365: HP:0003110 Abnormality of urine homeostasis
|
|
GS174925: HP:0000769 Abnormality of the breast
|
|
GS136673: skull morphology 12 (Skull12, Published QTL Chr 9)
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS207058: GO:0045283 fumarate reductase complex
|
|
GS171993: HP:0100631 Neoplasm of the adrenal gland
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS191477: GO:0045333 cellular respiration
|
|
GS172307: HP:0100696 Bone cysts
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS123977: 2,6-dichloro-4-nitrophenol interacting genes (MeSH:C015802) in CTD
|
|
GS171637: HP:0008872 Feeding difficulties in infancy
|
|
GS172637: HP:0010460 Abnormality of the female genitalia
|
|
GS129137: fecundity QTL 4 (Fecq4 Published QTL Chr 9)
|
|
GS181271: GO:0005740 mitochondrial envelope
|
|
GS171438: HP:0008776 Abnormality of the renal artery
|
|
GS135233: activity-distance traveled 4 (Actd4, Published QTL Chr 9)
|
|
GS35566: Cerebellum Gene expression correlates of Morphine photocell counts minutes 0-15 in Females BXD
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS180164: GO:0008150 biological_process
|
|
GS170213: MP:0004181 abnormal carotid artery morphology
|
|
GS171550: HP:0001064 Diaphoresis
|
|
GS173092: HP:0004375 Neoplasm of the nervous system
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS173962: HP:0001581 Recurrent skin infections
|
|
GS167505: MP:0008762 embryonic lethality
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS208854: GO:0045273 respiratory chain complex II
|
|
GS171915: HP:0002666 Pheochromocytoma
|
|
GS135374: body length 4 (Bdln4, Published QTL Chr 9)
|
|
GS194434: GO:0051186 cofactor metabolic process
|
|
GS173584: HP:0003345 Elevated urinary norepinephrine
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS173476: HP:0002311 Incoordination
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS164262: MP:0002080 prenatal lethality
|
|
GS168762: MP:0005423 abnormal somatic nervous system physiology
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS190954: GO:0009056 catabolic process
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS179711: GO:0042773 ATP synthesis coupled electron transport
|
|
GS166156: MP:0011096 complete embryonic lethality between implantation and somite formation
|
|
GS174235: HP:0006715 Glomus tympanicum paraganglioma
|
|
GS196559: GO:0019866 organelle inner membrane
|
|
GS177219: GO:0035383 thioester metabolic process
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS170917: HP:0100852 Abnormal fear/anxiety-related behavior
|
|
GS176464: HP:0100242 Sarcoma
|
|
GS194657: GO:0046906 tetrapyrrole binding
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186210: GO:0022900 electron transport chain
|
|
GS171927: HP:0100570 Carcinoid
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS175391: HP:0011004 Abnormality of the systemic arterial tree
|
|
GS174612: HP:0001600 Abnormality of the larynx
|
|
GS180799: GO:0006091 generation of precursor metabolites and energy
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS172027: HP:0000360 Tinnitus
|
|
GS174644: HP:0000953 Hyperpigmentation of the skin
|
|
GS194047: GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors
|
|
GS175815: HP:0011025 Abnormality of cardiovascular system physiology
|
|
GS172358: HP:0003117 Abnormality of circulating hormone level
|
|
GS204135: GO:0009060 aerobic respiration
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS181962: GO:0016491 oxidoreductase activity
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS202367: GO:0048039 ubiquinone binding
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS173335: HP:0004363 Abnormality of calcium homeostasis
|
|
GS175048: HP:0006824 Cranial nerve paralysis
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS173159: HP:0002239 Gastrointestinal hemorrhage
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS176142: HP:0001034 Hypermelanotic macule
|
|
GS173372: HP:0011297 Abnormality of the digits
|
|
GS135660: cocaine related behavior 8 (Cocrb8, Published QTL Chr 9)
|
|
GS136550: proteinuria 3 (Ptnu3, Published QTL Chr 9)
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS165528: MP:0005379 endocrine/exocrine gland phenotype
|
|
GS1777: Tabakoff et al 2003: Differential Gene Expression of acute functional tolerance to an incoordinating effect of ethanol (HAFT1 vs LAFT1)
|
|
GS164744: MP:0001730 embryonic growth arrest
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS198579: GO:0006119 oxidative phosphorylation
|
|
GS171209: HP:0000093 Proteinuria
|
|
GS171893: HP:0011458 Abdominal symptom
|
|
GS125104: Ethionine interacting genes (MeSH:D005001) in CTD
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS173751: HP:0000998 Hypertrichosis
|
|
GS175808: HP:0011028 Abnormality of blood circulation
|
|
GS171211: HP:0000091 Abnormality of the renal tubule
|
|
GS191106: GO:0044464 cell part
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS182174: GO:0031966 mitochondrial membrane
|
|
GS135485: bone response to mechanical loading 5 (Brml5, Published QTL Chr 9)
|
|
GS172519: HP:0001342 Cerebral hemorrhage
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS136009: haloperidol-induced catelepsy 5 (Hpic5, Published QTL Chr 9)
|
|
GS172416: HP:0002242 Abnormality of the intestine
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS176241: HP:0010935 Abnormality of the upper urinary tract
|
|
GS171453: HP:0003674 Onset
|
|
GS35656: Cerebellum Gene expression correlates of Morphine photocell counts minutes 60-75 in Females BXD
|
|
GS84210: alcohol preference QTL 1 (Alpq1 Published QTL, Chr 9)
|
|
GS173934: HP:0001673 Tachycardia (with pheochromocytoma)
|
|
GS174378: HP:0000518 Cataract
|
|
GS84208: METH responses for home cage activity (Published QTL, Chr 9)
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS174292: HP:0011968 Feeding difficulties
|
|
GS197078: GO:0005506 iron ion binding
|
|
GS122634: Ketone Bodies interacting genes (MeSH:D007657) in CTD
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS173191: HP:0012099 Abnormality of circulating catecholamine level
|
|
GS83992: cocaine related behavior 8 (Cocrb8, Published QTL, Chr 9)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS203056: GO:0022904 respiratory electron transport chain
|
|
GS208978: GO:0043169 cation binding
|
|
GS135768: experimental allergic encephalomyelitis susceptibility 9 (Eae9, Published QTL Chr 9)
|
|
GS163205: MP:0005643 decreased dopamine level
|
|
GS173990: HP:0000502 Abnormality of the conjunctiva
|
|
GS164126: MP:0001388 abnormal stationary movement
|
|
GS175809: HP:0011029 Internal hemorrhage
|
|
GS173482: HP:0000875 Episodic hypertension
|
|
GS167251: MP:0003438 abnormal carotid body physiology
|
|
GS174920: HP:0000766 Abnormality of the sternum
|
|
GS175941: HP:0100835 Benign neoplasm of the central nervous system
|
|
GS135474: brachyury modifier 1 (Brm1, Published QTL Chr 9)
|
|
GS84218: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS175523: HP:0000008 Abnormality of female internal genitalia
|
|
GS135949: HDL QTL 17 (Hdlq17, Published QTL Chr 9)
|
|
GS177913: GO:0046906 tetrapyrrole binding
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS198059: GO:0005740 mitochondrial envelope
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS174919: HP:0000767 Pectus excavatum
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS197593: GO:0006091 generation of precursor metabolites and energy
|
|
GS176672: HP:0000980 Pallor
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS175889: HP:0100013 Neoplasm of the breast
|
|
GS84220: morphine antinociception (Published QTL, Chr 9)
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS173554: HP:0005374 Cellular immunodeficiency
|
|
GS35641: Cerebellum Gene expression correlates of Morphine photocell counts minutes 45-60 in Females BXD
|
|
GS84212: ethanol consumption 3 (Etohc3, Published QTL, Chr 9)
|
|
GS189860: GO:0043167 ion binding
|
|
GS176642: HP:0011355 Localized skin lesion
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS163997: MP:0011655 abnormal systemic artery morphology
|
|
GS174038: HP:0011976 Elevated urinary catecholamines
|
|
GS194556: GO:0031975 envelope
|
|
GS175558: HP:0002516 Increased intracranial pressure
|
|
GS136809: tuberculosis severity 2 (Tbs2, Published QTL Chr 9)
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS125040: Thioacetamide interacting genes (MeSH:D013853) in CTD
|
|
GS191854: GO:0015980 energy derivation by oxidation of organic compounds
|
|
GS35626: Cerebellum Gene expression correlates of Morphine photocell counts minutes 30-45 in Females BXD
|
|
GS177814: GO:0031975 envelope
|
|
GS184446: GO:0044429 mitochondrial part
|
|
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
|
|
GS174127: HP:0009903 Conjunctival nodules
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS172364: HP:0003111 Abnormality of ion homeostasis
|
|
GS129130: epilepsy 4 (El4 Published QTL Chr 9)
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS123351: Omeprazole interacting genes (MeSH:D009853) in CTD
|
|
GS136118: body length 5 (Lgth5, Published QTL Chr 9)
|
|
GS199314: GO:0006732 coenzyme metabolic process
|
|
GS175886: HP:0007378 Neoplasm of the gastrointestinal tract
|
|
GS135316: alcohol preference 5 QTL (Ap5q, Published QTL Chr 9)
|
|
GS174375: HP:0002027 Abdominal pain
|
|
GS173928: HP:0001675 Rhythm disturbances associated with pheochromocytoma
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS165163: MP:0006205 embryonic lethality between implantation and somite formation
|
|
GS173693: HP:0001649 Tachycardia
|
|
GS175319: HP:0005266 Intestinal polyps
|
|
GS199478: GO:0020037 heme binding
|
|
GS174648: HP:0000957 Cafe-au-lait spot
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS184447: GO:0044424 intracellular part
|
|
GS207862: GO:0009056 catabolic process
|
|
GS171394: HP:0000174 Abnormality of the palate
|
|
GS201364: GO:0045257 succinate dehydrogenase complex (ubiquinone)
|
|
GS84219: cocaine related behavior (Published QTL, Chr 9)
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS193712: GO:0006121 mitochondrial electron transport, succinate to ubiquinone
|
|
GS135676: cholesterol QTL 5 (Cq5, Published QTL Chr 9)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS174081: HP:0004322 Short stature
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS197357: GO:0005746 mitochondrial respiratory chain
|
|
GS136140: lithogenic gene 20 (Lith20, Published QTL Chr 9)
|
|
GS195139: GO:0055114 oxidation-reduction process
|
|
GS121370: Clofibrate interacting genes (MeSH:D002994) in CTD
|
|
GS176759: HP:0000982 Palmoplantar keratoderma
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS164263: MP:0002083 premature death
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS175572: HP:0002886 Vagal paraganglioma
|
|
GS182834: GO:0005623 cell
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS177042: HP:0001920 Renal artery stenosis
|
|
GS194433: GO:0051187 cofactor catabolic process
|
|
GS167922: MP:0000959 abnormal somatic sensory system morphology
|
|
GS166710: MP:0002163 abnormal gland morphology
|
|
GS176496: HP:0100780 Conjunctival hamartomas
|
|
GS196943: GO:0008152 metabolic process
|
|
GS180305: GO:0016310 phosphorylation
|
|
GS174810: HP:0001635 Congestive heart failure
|